Holen Sie sich die Stockscreener-App
10.60
9.28%
0.90
Handel nachbörslich:
10.60
Schlusskurs vom Vortag:
$9.70
Offen:
$9.65
24-Stunden-Volumen:
1.02M
Relative Volume:
1.48
Marktkapitalisierung:
$629.93M
Einnahmen:
$133.62M
Nettoeinkommen (Verlust:
$-177.37M
KGV:
-3.6678
EPS:
-2.89
Netto-Cashflow:
$23.50M
1W Leistung:
+18.57%
1M Leistung:
-19.70%
6M Leistung:
-49.72%
1J Leistung:
-42.33%
1-Tages-Spanne:
$9.46
$10.98
1-Wochen-Bereich:
$8.82
$10.98
52-Wochen-Spanne:
$7.16
$27.24
Xencor Inc Stock (XNCR) Company Profile
Firmenname
Xencor Inc
Sektor
Branche
Telefon
626-305-5900
Adresse
465 N. HALSTEAD ST., PASADENA, CA
Vergleichen Sie XNCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
10.60 | 629.93M | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | Bestätigt | BTIG Research | Buy |
| 2024-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | Eingeleitet | BofA Securities | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-10-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Overweight |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-11 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-01-21 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-02-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | Eingeleitet | Barclays | Underweight |
| 2020-02-25 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-01-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-11-20 | Fortgesetzt | Guggenheim | Neutral |
| 2019-08-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-08-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | Eingeleitet | Mizuho | Buy |
| 2019-04-12 | Eingeleitet | Guggenheim | Buy |
| 2019-03-27 | Eingeleitet | Berenberg | Buy |
| 2019-03-15 | Eingeleitet | Raymond James | Outperform |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-03-28 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-03-02 | Eingeleitet | Instinet | Neutral |
| 2017-03-02 | Bestätigt | Wedbush | Outperform |
| 2016-10-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-12-22 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-08-05 | Bestätigt | MLV & Co | Buy |
| 2015-02-12 | Bestätigt | Oppenheimer | Outperform |
| 2015-01-28 | Bestätigt | MLV & Co | Buy |
| 2014-07-11 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Xencor Inc Aktie (XNCR) Neueste Nachrichten
Xencor Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
William Blair starts Xencor stock with Outperform rating By Investing.com - Investing.com South Africa
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Rating of “Buy” by Analysts - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Acquires 179,526 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Wellington Management Group LLP Purchases Shares of 27,491 Xencor, Inc. (NASDAQ:XNCR) - The AM Reporter
27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World
Xencor CFO Cornelissen sells $30,232 in company stock By Investing.com - Investing.com India
Xencor CFO sells $30,232 in company stock - Investing.com
Xencor CFO Cornelissen sells $30,232 in company stock - Investing.com
Xencor CFO sells $30,232 in company stock By Investing.com - Investing.com South Africa
Xencor (NASDAQ:XNCR) Sets New 1-Year LowHere's Why - MarketBeat
Xencor, Inc.: No Major Near Term Catalysts (NASDAQ:XNCR) - Seeking Alpha
Xencor (XNCR) Upgraded to Buy: Here's Why - Yahoo Finance
Federal Circuit’s Xencor Decision: Considerations for Jepson Claims and Implications for 35 U.S.C. § 101 Analysis - NatLawReview.com
Xencor’s SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com Canada
Xencor’s SWOT analysis: biotech stock faces pivotal year ahead - Investing.com India
American Century Companies Inc. Has $2.63 Million Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Vanguard Group Inc. - Defense World
KLP Kapitalforvaltning AS Invests $280,000 in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Prudential Financial Inc. - Defense World
Corebridge Financial Inc. Has $826,000 Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor stock hits 52-week low at $9.34 amid market challenges - Investing.com
Xencor stock hits 52-week low at $9.34 amid market challenges By Investing.com - Investing.com South Africa
End of the Road for Jepson Format Claims in the Life Sciences? - JD Supra
Teacher Retirement System of Texas Has $428,000 Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely - simplywall.st
Raymond James Financial Inc. Acquires New Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Swiss National Bank - Defense World
Even Jepson Preambles Require Written Description Support - The National Law Review
PNC Financial Services Group Inc. Raises Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor stock touches 52-week low at $12.53 amid market challenges By Investing.com - Investing.com South Africa
Xencor stock touches 52-week low at $12.53 amid market challenges - Investing.com India
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Buy” from Brokerages - Defense World
When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Boosts Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Armenian Reporter
Charles Schwab Investment Management Inc. Purchases 3,652 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Amundi Acquires 24,494 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Bank of New York Mellon Corp Purchases 18,586 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Federal Circuit Rules Jepson Claims Need Full Written Description: Another Nail in the Coffin - Patently-O
Xencor (NASDAQ:XNCR) Stock Rating Lowered by StockNews.com - Defense World
Fed. Circ. Dings Antibody Patent App For Lacking Description - Law360
Xencor Appoints Todd Simpson To Board Of Directors -March 13, 2025 at 05:31 pm EDT - Marketscreener.com
Xencor Appoints Todd Simpson to Board of Directors - sharewise
Xencor Strengthens Board with Veteran Biotech CFO Behind Seagen's Multi-Billion Success - StockTitan
Xencor’s SVP sells $78,047 in stock By Investing.com - Investing.com India
Xencor’s EVP Nancy Valente sells $34,876 in stock By Investing.com - Investing.com Canada
Antibody Humanization Market Critical Analysis with Expert Opinion: Genentech, Adimab, Xencor - openPR
Finanzdaten der Xencor Inc-Aktie (XNCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):